Table of Contents 1 Subcutaneous Injection Immunoglobulin Market Overview 1.1 Product Overview and Scope of Subcutaneous Injection Immunoglobulin 1.2 Subcutaneous Injection Immunoglobulin Segment by Type 1.2.1 Global Subcutaneous Injection Immunoglobulin Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 10% Purity 1.2.3 20% Purity 1.3 Subcutaneous Injection Immunoglobulin Segment by Application 1.3.1 Subcutaneous Injection Immunoglobulin Sales Comparison by Application: 2020 VS 2026 1.3.2 Primary Immunodeficiency 1.3.3 Secondary Immunodeficiency 1.3.4 Others 1.4 Global Subcutaneous Injection Immunoglobulin Market Size Estimates and Forecasts 1.4.1 Global Subcutaneous Injection Immunoglobulin Revenue 2015-2026 1.4.2 Global Subcutaneous Injection Immunoglobulin Sales 2015-2026 1.4.3 Subcutaneous Injection Immunoglobulin Market Size by Region: 2020 Versus 2026 2 Global Subcutaneous Injection Immunoglobulin Market Competition by Manufacturers 2.1 Global Subcutaneous Injection Immunoglobulin Sales Market Share by Manufacturers (2015-2020) 2.2 Global Subcutaneous Injection Immunoglobulin Revenue Share by Manufacturers (2015-2020) 2.3 Global Subcutaneous Injection Immunoglobulin Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Subcutaneous Injection Immunoglobulin Manufacturing Sites, Area Served, Product Type 2.5 Subcutaneous Injection Immunoglobulin Market Competitive Situation and Trends 2.5.1 Subcutaneous Injection Immunoglobulin Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Subcutaneous Injection Immunoglobulin Players (Opinion Leaders) 3 Subcutaneous Injection Immunoglobulin Retrospective Market Scenario by Region 3.1 Global Subcutaneous Injection Immunoglobulin Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Subcutaneous Injection Immunoglobulin Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Subcutaneous Injection Immunoglobulin Market Facts & Figures by Country 3.3.1 North America Subcutaneous Injection Immunoglobulin Sales by Country 3.3.2 North America Subcutaneous Injection Immunoglobulin Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Subcutaneous Injection Immunoglobulin Market Facts & Figures by Country 3.4.1 Europe Subcutaneous Injection Immunoglobulin Sales by Country 3.4.2 Europe Subcutaneous Injection Immunoglobulin Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Subcutaneous Injection Immunoglobulin Market Facts & Figures by Region 3.5.1 Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Region 3.5.2 Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Subcutaneous Injection Immunoglobulin Market Facts & Figures by Country 3.6.1 Latin America Subcutaneous Injection Immunoglobulin Sales by Country 3.6.2 Latin America Subcutaneous Injection Immunoglobulin Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Subcutaneous Injection Immunoglobulin Market Facts & Figures by Country 3.7.1 Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country 3.7.2 Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Subcutaneous Injection Immunoglobulin Historic Market Analysis by Type 4.1 Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2015-2020) 4.2 Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2015-2020) 4.3 Global Subcutaneous Injection Immunoglobulin Price Market Share by Type (2015-2020) 4.4 Global Subcutaneous Injection Immunoglobulin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Subcutaneous Injection Immunoglobulin Historic Market Analysis by Application 5.1 Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2015-2020) 5.2 Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2015-2020) 5.3 Global Subcutaneous Injection Immunoglobulin Price by Application (2015-2020) 6 Company Profiles and Key Figures in Subcutaneous Injection Immunoglobulin Business 6.1 Shire (Baxalta) 6.1.1 Corporation Information 6.1.2 Shire (Baxalta) Description, Business Overview and Total Revenue 6.1.3 Shire (Baxalta) Subcutaneous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Shire (Baxalta) Products Offered 6.1.5 Shire (Baxalta) Recent Development 6.2 Grifols 6.2.1 Grifols Subcutaneous Injection Immunoglobulin Production Sites and Area Served 6.2.2 Grifols Description, Business Overview and Total Revenue 6.2.3 Grifols Subcutaneous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Grifols Products Offered 6.2.5 Grifols Recent Development 6.3 CSL 6.3.1 CSL Subcutaneous Injection Immunoglobulin Production Sites and Area Served 6.3.2 CSL Description, Business Overview and Total Revenue 6.3.3 CSL Subcutaneous Injection Immunoglobulin Sales, Revenue and Gross Margin (2015-2020) 6.3.4 CSL Products Offered 6.3.5 CSL Recent Development 7 Subcutaneous Injection Immunoglobulin Manufacturing Cost Analysis 7.1 Subcutaneous Injection Immunoglobulin Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Subcutaneous Injection Immunoglobulin 7.4 Subcutaneous Injection Immunoglobulin Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Subcutaneous Injection Immunoglobulin Distributors List 8.3 Subcutaneous Injection Immunoglobulin Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Subcutaneous Injection Immunoglobulin Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Subcutaneous Injection Immunoglobulin by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Subcutaneous Injection Immunoglobulin by Type (2021-2026) 10.2 Subcutaneous Injection Immunoglobulin Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Subcutaneous Injection Immunoglobulin by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Subcutaneous Injection Immunoglobulin by Application (2021-2026) 10.3 Subcutaneous Injection Immunoglobulin Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Subcutaneous Injection Immunoglobulin by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Subcutaneous Injection Immunoglobulin by Region (2021-2026) 10.4 North America Subcutaneous Injection Immunoglobulin Estimates and Projections (2021-2026) 10.5 Europe Subcutaneous Injection Immunoglobulin Estimates and Projections (2021-2026) 10.6 Asia Pacific Subcutaneous Injection Immunoglobulin Estimates and Projections (2021-2026) 10.7 Latin America Subcutaneous Injection Immunoglobulin Estimates and Projections (2021-2026) 10.8 Middle East and Africa Subcutaneous Injection Immunoglobulin Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Subcutaneous Injection Immunoglobulin Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Subcutaneous Injection Immunoglobulin Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Subcutaneous Injection Immunoglobulin Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Subcutaneous Injection Immunoglobulin Manufacturers Covered in This Study Table 5. Global Subcutaneous Injection Immunoglobulin Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Subcutaneous Injection Immunoglobulin Sales Share by Manufacturers (2015-2020) Table 7. Global Subcutaneous Injection Immunoglobulin Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Subcutaneous Injection Immunoglobulin Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Subcutaneous Injection Immunoglobulin Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Subcutaneous Injection Immunoglobulin Sales Sites and Area Served Table 11. Manufacturers Subcutaneous Injection Immunoglobulin Product Types Table 12. Global Subcutaneous Injection Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Subcutaneous Injection Immunoglobulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Injection Immunoglobulin as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Subcutaneous Injection Immunoglobulin Players Table 16. Global Subcutaneous Injection Immunoglobulin Sales (K Units) by Region (2015-2020) Table 17. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2015-2020) Table 18. Global Subcutaneous Injection Immunoglobulin Revenue (Million US$) by Region (2015-2020) Table 19. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2015-2020) Table 20. North America Subcutaneous Injection Immunoglobulin Sales by Country (2015-2020) (K Units) Table 21. North America Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2015-2020) Table 22. North America Subcutaneous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million) Table 23. North America Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2015-2020) Table 24. Europe Subcutaneous Injection Immunoglobulin Sales by Country (2015-2020) (K Units) Table 25. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2015-2020) Table 26. Europe Subcutaneous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2015-2020) Table 32. Latin America Subcutaneous Injection Immunoglobulin Sales by Country (2015-2020) (K Units) Table 33. Latin America Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2015-2020) Table 34. Latin America Subcutaneous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue Market Share by Country (2015-2020) Table 40. Global Subcutaneous Injection Immunoglobulin Sales (K Units) by Type (2015-2020) Table 41. Global Subcutaneous Injection Immunoglobulin Sales Share by Type (2015-2020) Table 42. Global Subcutaneous Injection Immunoglobulin Revenue (Million US$) by Type (2015-2020) Table 43. Global Subcutaneous Injection Immunoglobulin Revenue Share by Type (2015-2020) Table 44. Global Subcutaneous Injection Immunoglobulin Price (USD/Unit) by Type (2015-2020) Table 45. Global Subcutaneous Injection Immunoglobulin Sales (K Units) by Application (2015-2020) Table 46. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2015-2020) Table 47. Global Subcutaneous Injection Immunoglobulin Sales Growth Rate by Application (2015-2020) Table 48. Shire (Baxalta) Subcutaneous Injection Immunoglobulin Corporation Information Table 49. Shire (Baxalta) Description and Business Overview Table 50. Shire (Baxalta) Subcutaneous Injection Immunoglobulin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Shire (Baxalta) Main Product Table 52. Shire (Baxalta) Recent Development Table 53. Grifols Subcutaneous Injection Immunoglobulin Corporation Information Table 54. Grifols Corporation Information Table 55. Grifols Subcutaneous Injection Immunoglobulin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. Grifols Main Product Table 57. Grifols Recent Development Table 58. CSL Subcutaneous Injection Immunoglobulin Corporation Information Table 59. CSL Corporation Information Table 60. CSL Subcutaneous Injection Immunoglobulin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. CSL Main Product Table 62. CSL Recent Development Table 63. Sales Base and Market Concentration Rate of Raw Material Table 64. Key Suppliers of Raw Materials Table 65. Subcutaneous Injection Immunoglobulin Distributors List Table 66. Subcutaneous Injection Immunoglobulin Customers List Table 67. Market Key Trends Table 68. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 69. Key Challenges Table 70. Global Subcutaneous Injection Immunoglobulin Sales (K Units) Forecast by Type (2021-2026) Table 71. Global Subcutaneous Injection Immunoglobulin Sales Market Share Forecast by Type (2021-2026) Table 72. Global Subcutaneous Injection Immunoglobulin Revenue (Million US$) Forecast by Type (2021-2026) Table 73. Global Subcutaneous Injection Immunoglobulin Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 74. Global Subcutaneous Injection Immunoglobulin Sales (K Units) Forecast by Application (2021-2026) Table 75. Global Subcutaneous Injection Immunoglobulin Revenue (Million US$) Forecast by Application (2021-2026) Table 76. Global Subcutaneous Injection Immunoglobulin Sales (K Units) Forecast by Region (2021-2026) Table 77. Global Subcutaneous Injection Immunoglobulin Sales Market Share Forecast by Region (2021-2026) Table 78. Global Subcutaneous Injection Immunoglobulin Revenue Forecast by Region (2021-2026) (US$ Million) Table 79. Global Subcutaneous Injection Immunoglobulin Revenue Market Share Forecast by Region (2021-2026) Table 80. Research Programs/Design for This Report Table 81. Key Data Information from Secondary Sources Table 82. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Subcutaneous Injection Immunoglobulin Figure 2. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type: 2020 VS 2026 Figure 3. 10% Purity Product Picture Figure 4. 20% Purity Product Picture Figure 5. Global Subcutaneous Injection Immunoglobulin Consumption Market Share by Application: 2020 VS 2026 Figure 6. Primary Immunodeficiency Figure 7. Secondary Immunodeficiency Figure 8. Others Figure 9. Global Subcutaneous Injection Immunoglobulin Market Size 2015-2026 (US$ Million) Figure 10. Global Subcutaneous Injection Immunoglobulin Sales Capacity (K Units) (2015-2026) Figure 11. Global Subcutaneous Injection Immunoglobulin Market Size Market Share by Region: 2020 Versus 2026 Figure 12. Subcutaneous Injection Immunoglobulin Sales Share by Manufacturers in 2020 Figure 13. Global Subcutaneous Injection Immunoglobulin Revenue Share by Manufacturers in 2019 Figure 14. The Global 5 and 10 Largest Players: Market Share by Subcutaneous Injection Immunoglobulin Revenue in 2019 Figure 15. Subcutaneous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 16. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2015-2020) Figure 17. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Region in 2019 Figure 18. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2015-2020) Figure 19. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region in 2019 Figure 20. North America Subcutaneous Injection Immunoglobulin Sales Market Share by Country in 2019 Figure 21. North America Subcutaneous Injection Immunoglobulin Revenue Market Share by Country in 2019 Figure 22. U.S. Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 23. U.S. Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 24. Canada Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 25. Canada Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Country in 2019 Figure 27. Europe Subcutaneous Injection Immunoglobulin Revenue Market Share by Country in 2019 Figure 28. Germany Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 29. Germany Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 30. France Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 31. France Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. U.K. Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 33. U.K. Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. Italy Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 35. Italy Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Russia Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 37. Russia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Asia Pacific Subcutaneous Injection Immunoglobulin Sales Market Share by Region in 2019 Figure 39. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue Market Share by Region in 2019 Figure 40. China Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 41. China Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. Japan Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 43. Japan Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. South Korea Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 45. South Korea Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. India Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 47. India Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Australia Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 49. Australia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Taiwan Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 51. Taiwan Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Indonesia Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 53. Indonesia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Thailand Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 55. Thailand Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Malaysia Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 57. Malaysia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Philippines Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 59. Philippines Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Vietnam Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 61. Vietnam Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Latin America Subcutaneous Injection Immunoglobulin Sales Market Share by Country in 2019 Figure 63. Latin America Subcutaneous Injection Immunoglobulin Revenue Market Share by Country in 2019 Figure 64. Mexico Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 65. Mexico Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Brazil Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 67. Brazil Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Argentina Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 69. Argentina Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share by Country in 2019 Figure 71. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue Market Share by Country in 2019 Figure 72. Turkey Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 73. Turkey Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Saudi Arabia Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 75. Saudi Arabia Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. U.A.E Subcutaneous Injection Immunoglobulin Sales Growth Rate (2015-2020) (K Units) Figure 77. U.A.E Subcutaneous Injection Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Sales Market Share of Subcutaneous Injection Immunoglobulin by Type (2015-2020) Figure 79. Sales Market Share of Subcutaneous Injection Immunoglobulin by Type in 2019 Figure 80. Revenue Share of Subcutaneous Injection Immunoglobulin by Type (2015-2020) Figure 81. Revenue Market Share of Subcutaneous Injection Immunoglobulin by Type in 2019 Figure 82. Global Subcutaneous Injection Immunoglobulin Sales Growth by Type (2015-2020) (K Units) Figure 83. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2015-2020) Figure 84. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application in 2019 Figure 85. Global Revenue Share of Subcutaneous Injection Immunoglobulin by Application (2015-2020) Figure 86. Global Revenue Share of Subcutaneous Injection Immunoglobulin by Application in 2020 Figure 87. Shire (Baxalta) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Grifols Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. CSL Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Price Trend of Key Raw Materials Figure 91. Manufacturing Cost Structure of Subcutaneous Injection Immunoglobulin Figure 92. Manufacturing Process Analysis of Subcutaneous Injection Immunoglobulin Figure 93. Subcutaneous Injection Immunoglobulin Industrial Chain Analysis Figure 94. Channels of Distribution Figure 95. Distributors Profiles Figure 96. Porter's Five Forces Analysis Figure 97. North America Subcutaneous Injection Immunoglobulin Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 98. North America Subcutaneous Injection Immunoglobulin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 99. Europe Subcutaneous Injection Immunoglobulin Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 100. Europe Subcutaneous Injection Immunoglobulin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 101. Latin America Subcutaneous Injection Immunoglobulin Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 102. Latin America Subcutaneous Injection Immunoglobulin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 103. Middle East and Africa Subcutaneous Injection Immunoglobulin Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 104. Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 105. Asia Pacific Subcutaneous Injection Immunoglobulin Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 106. Asia Pacific Subcutaneous Injection Immunoglobulin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 107. Bottom-up and Top-down Approaches for This Report Figure 108. Data Triangulation Figure 109. Key Executives Interviewed

Shire (Baxalta) Grifols CSL